Navigation Links
GENFIT: Strong U.S. Exposure for Its Biomarker Activity
Date:1/6/2011

LILLE, France and CAMBRIDGE, Mass., Jan. 6, 2011 /PRNewswire/ -- GENFIT (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announced its presence at two U.S. events: the 28th J.P. Morgan Healthcare Conference (from January 11th to 14th, 2011) and the Biotech Showcase (from January 10th to 12th, 2011).

At these events, the Company will give a progress update on its research programs, in particular those dedicated to the theranostic field, that are based on GENFIT's proprietary microparticle capture and characterization technologies for the identification of novel biomarkers:

- The BMGFT01 program, through a translational approach combining specific preclinical models and clinical cohorts of patients at high cardiovascular risk, is dedicated to the discovery of early markers of atherosclerosis and vulnerable plaque via the analysis of plasmatic microparticle signatures.

-  The BMGFT02 program, in the field of type 2 diabetes and its early stages, aims to identify novel biomarkers of pancreatic beta cell dysfunction, in particular through two major clinical studies (DECODIAB and ABOS) involving the longitudinal follow-up of more than 1000 patients.

Jean-Francois Mouney, Chairman of GENFIT's Management Board, stated: "At a time of intense negotiations for our leading drug candidate GFT505, we are proud to present the significant progress that GENFIT has made on its programs linked to the detection of early biomarkers of diabetes and atherosclerosis. For the past two years, GENFIT has been working on the development of a breakthrough technology in this domain. This technology will provide, on the one hand, a rapid, targeted, and predictive follow-up of the efficacy of new treatments for certain metabolic pathologies, and, on the other hand, new
'/>"/>

SOURCE GENFIT
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Medicine Announces Strong Second Quarter 2008 Results
2. Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
3. Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability
4. Senetek Affirms Strong Financial Position
5. Strong elasticity size effects in ZnO nanowires
6. Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan
7. Cephalon Reports Another Strong Quarter
8. Shires New Product Portfolio Delivers Strong Quarterly Performance
9. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
10. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
11. ACORN CRO Continues Growth in Strong Third Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Cynvenio, a cancer diagnostics company focused on ... of tumor cells in the bloodstream, today announced that ... support application powered by CollabRx, Inc. , Available ... Therapy Finder will provide breast cancer patients and their ...
(Date:1/15/2014)... Jan. 15, 2014 ­ RedBrick Health , a ... technology, today announces that EmblemHealth , the ... company, is now providing the RedBrick Compass health assessment, ... to all of its members. EmblemHealth is among the ...
(Date:1/15/2014)... IPSWICH, England , January 15, 2014 ... to win races on the Formula 1 track could help ... between McLaren Applied Technologies (MAT), Stowhealth (a GP surgery based ... funded by healthcare provider Simplyhealth. Telemetry technology, which ...
(Date:1/15/2014)... 2014 Two champions of science, technology, ... of an annual competition for middle and high school ... innovative STEM study. The competition presents students with real-world ... Engineering Aptitude, Mathematics, and Sciences is a program ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 2EmblemHealth Selects RedBrick Health to Power its Next-Generation Health Engagement and Behavior Change System 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
... 26 Mylan Inc. (NYSE: MYL ),today ... Vice President,Global Corporate Communication and Public Relations. Mr. ... communications and provide,communications and public relations counsel to ... various roles across the Company., Mr. Zylstra ...
... Inc.,(Nasdaq: NGSX ), a biopharmaceutical company focused ... it is scheduled to present,on Wednesday, November 28, ... New York City. Anthony DiTonno, President and Chief ... Financial Officer,will be available to respond to questions ...
... DECATUR, Ill., Nov. 26 Archer Daniels Midland,Company ... Camp, executive vice,president, has elected to retire by ... on a special assignment to advance the,Company,s business ... now transitions to the Company,s strategic planning group,under ...
Cached Biology Technology:Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations 2NeurogesX to Present at Lazard Capital Markets Healthcare Conference 2NeurogesX to Present at Lazard Capital Markets Healthcare Conference 3ADM Executive Vice President Bill Camp to Retire 2
(Date:4/17/2014)... new modeling study suggests that fish consumption advisories ... exposure to long-lived contaminants like persistent organic pollutants ... team of researchers including University of Toronto Scarborough ... looks at how different levels of environmental contamination, ... of chemicals in the body influenced exposure in ...
(Date:4/17/2014)... release is available in German . ... to recognise objects; they also provide us with a continuous ... turn around, fall or sit still in a car ... trace on our retinas. Seemingly without effort, our brain calculates ... a stable position and a steady gaze during our own ...
(Date:4/17/2014)... House honored Clemson professor Rajendra Singh Thursday as ... promote and expand solar deployment in the residential, ... Houser Banks Professor of Electrical and Computer Engineering ... is considered a local hero leading the charge ... opportunity in solar power and driving policy changes ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4White House honors Clemson professor as 'Champion of Change' for solar deployment 2
... with HIV is difficult under the best of circumstances, ... become particularly perilous in intricate ways that are only ... Center on HIV (ARCH) funded by a new $7.5-million, ... University scientists will study the health effects of drinking ...
... Japan, 20 October 2010 The economic importance of the world,s ... a result of an international assessment showcasing the enormous economic ... as the social and economic costs of their loss, was ... report launched today by TEEB study leader, Pavan Sukhdev. ...
... D.C. (October 19, 2010) -- We talk about synchronization ... get in synch. And synchronous behavior underlies many natural ... cause oscillators -- which are common electronic components that ... synch or fall out of synch, is necessary to ...
Cached Biology News:$7.5M grant to fund research on interaction of drinking and HIV infection 2$7.5M grant to fund research on interaction of drinking and HIV infection 3TEEB report puts world's natural assets on the global political radar 2TEEB report puts world's natural assets on the global political radar 3TEEB report puts world's natural assets on the global political radar 4TEEB report puts world's natural assets on the global political radar 5TEEB report puts world's natural assets on the global political radar 6
... Kit #4 detects apoptosis on the ... permeability of cell membranes. This kit contains ... iodide nucleic acid stains. YO-PRO-1 stain selectively ... cells and labels them with moderate green ...
Porcine TNF-alpha/TNFSF1A ELISpot Development Module...
Request Info...
5-bromo-4-chloro-3-indolyl b -D-galactopyranoside (X-Gal)...
Biology Products: